Knowledge-Based Systems,
Год журнала:
2022,
Номер
256, С. 109877 - 109877
Опубликована: Сен. 12, 2022
The
significance
of
machine-learning
approaches
in
the
healthcare
domain
has
grown
rapidly
owing
to
existence
enormous
amounts
data
and
well-established
simulation
models
algorithms.
digitization
health-related
data,
as
well
rapid
technological
advancements
are
accelerating
development
application
machine
learning
healthcare,
particularly
precision
medicine.
ultimate
goal
medicine
is
provide
personalized
medicine,
which
requires
tailoring
medical
decisions
each
patient
based
on
their
projected
disease
response.
In
this
study,
we
propose
a
cluster-applied
deep
reinforcement
learning-based
type
2
diabetes
treatment
recommendation
model
electronic
health
records
South
Koreans.
purpose
applying
clustering
algorithm
group
patients
who
similar
state,
boost
performance
learning,
build
more
realistic
support
clinicians,
develop
expert
systems
field
healthcare.
proposed
demonstrated
significant
by
decreasing
diabetes-related
checkup
measurements.
Furthermore,
delivered
high-quality
when
compared
with
existing
reinforcement-learning
methods.
Finally,
outcomes
were
validated
against
real-life
prescriptions
ensure
accuracy
findings.
Journal of Organizational and End User Computing,
Год журнала:
2022,
Номер
34(1), С. 1 - 14
Опубликована: Авг. 11, 2022
In
recent
decades,
healthcare
organizations
around
the
world
have
increasingly
appreciated
value
of
information
technologies
for
a
variety
applications.
Three
new
technological
advancements
that
are
impacting
smart
health
metaverse,
artificial
intelligence
(AI),
and
data
science.
The
metaverse
is
intersection
three
major
—
AI,
augmented
reality
(AR),
virtual
(VR).
Metaverse
provides
possibilities
potential
still
emerging.
increased
work
efficiency
enabled
by
science
in
hospitals
not
only
improves
patient
care
but
also
cuts
costs
workload
providers.
Artificial
intelligence,
coupled
with
machine
learning,
transforming
industry.
availability
big
enables
scientists
to
use
descriptive,
predictive,
prescriptive
analytics.
This
article
reviews
multiple
case
studies
literature
on
AI
applications
hospital
administration.
presents
unresolved
research
questions
challenges
context.
For
researchers,
addition
providing
good
synopsis
development
area,
this
identifies
possible
future
directions
discusses
health.
practitioners,
both
decision-makers
workers
practical
guidelines
management
model.
Remote Sensing,
Год журнала:
2022,
Номер
14(16), С. 3885 - 3885
Опубликована: Авг. 11, 2022
Timely
and
accurate
information
on
the
spatial
distribution
of
urban
trees
is
critical
for
sustainable
development,
management
planning.
Compared
with
satellite-based
remote
sensing,
Unmanned
Aerial
Vehicle
(UAV)
sensing
has
a
higher
temporal
resolution,
which
provides
new
method
identification
trees.
In
this
study,
we
aim
to
establish
an
efficient
practical
tree
by
combining
object-oriented
approach
random
forest
algorithm
using
UAV
multispectral
images.
Firstly,
image
was
segmented
multi-scale
segmentation
based
scale
determined
Estimation
Scale
Parameter
2
(ESP2)
tool
visual
discrimination.
Secondly,
spectral
features,
index
texture
features
geometric
were
combined
form
schemes
S1–S8,
S9,
consisting
selected
recursive
feature
elimination
(RFE)
method.
Finally,
classification
performed
nine
(RF),
support
vector
machine
(SVM)
k-nearest
neighbor
(KNN)
classifiers,
respectively.
The
results
show
that
RF
classifier
performs
better
than
SVM
KNN,
achieves
highest
accuracy
in
overall
(OA)
91.89%
Kappa
coefficient
(Kappa)
0.91.
This
study
reveals
have
negative
impact
classification,
other
three
types
positive
impact.
importance
ranking
map
shows
are
most
important
type
followed
features.
Most
species
high
accuracy,
but
Camphor
Cinnamomum
Japonicum
much
lower
species,
suggesting
cannot
accurately
distinguish
these
two
so
it
necessary
add
such
as
height
future
improve
accuracy.
illustrates
combination
images
powerful
classification.
World Journal of Gastroenterology,
Год журнала:
2022,
Номер
28(4), С. 432 - 448
Опубликована: Янв. 19, 2022
Liver
cancer
is
the
second
most
occurring
worldwide
and
one
of
leading
causes
cancer-related
deaths.
Hepatocellular
carcinoma
(HCC)
common
(80%-90%)
type
among
malignant
liver
cancers.
Sarcopenia
occurs
very
early
in
HCC
can
predict
provide
an
opportunity
to
improve
muscle
health
before
engaging
treatment
options
such
as
loco-regional,
systemic,
transplant
management.
Multiple
prognostic
stating
systems
have
been
developed
HCC,
Barcelona
Clinic
Cancer,
Child-Pugh
score
Albumin-Bilirubin
grade.
However,
evaluation
patients'
performance
status
a
major
limitation
these
scoring
systems.
In
this
review,
we
aim
summarize
current
knowledge
recent
advances
about
role
sarcopenia
cirrhosis
general,
while
focusing
specifically
on
HCC.
Additionally,
predicting
clinical
outcomes
prognostication
patients
undergoing
loco-regional
therapies,
resection,
transplantation
systematic
therapy
has
discussed.
A
literature
review
was
performed
using
databases
PubMed/MEDLINE,
EMBASE,
Cochrane,
Web
Science,
CINAHL
April
1,
2021,
identify
published
reports
independently
HCC-related
mortality
especially
treatments
surgical
systemic
therapies.
Basic
research
focused
evaluating
balance
anabolic
catabolic
pathways
responsible
for
health.
Early
studies
shown
promising
results
methods
which
potentially
increase
prognosis
patients.
As
it
Further,
measurement
obviate
confounding
caused
by
abdominal
ascites
The
use
add
existing
better
prognosticate
Clinical and Molecular Hepatology,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 5, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
complex
multifactorial
and
becoming
the
leading
cause
of
liver-related
morbidity
mortality.
MASLD
spans
from
isolated
steatosis
to
metabolic
steatohepatitis
(MASH),
that
may
progress
cirrhosis
hepatocellular
carcinoma
(HCC).
Genetic,
metabolic,
environmental
factors
strongly
contribute
heterogeneity
MASLD.
Lifestyle
intervention
weight
loss
represent
viable
treatment
for
Moreover,
Resmetirom,
thyroid
hormone
beta
receptor
agonist,
has
recently
been
approved
treatment.
However,
most
individuals
treated
did
not
respond
this
therapeutic
suggesting
need
more
tailored
approach
treat
Oligonucleotide-based
therapies,
namely
small-interfering
RNA
(siRNA)
antisense
oligonucleotide
(ASO),
have
developed
tackle
by
reducing
expression
genes
influencing
MASH
progression,
such
as
PNPLA3
HSD17B13.
Here,
we
review
latest
made
in
synthesis
development
oligonucleotide-based
agents
targeting
genetic
determinants
MASH.
Clinical and Molecular Hepatology,
Год журнала:
2023,
Номер
30(1), С. 64 - 79
Опубликована: Янв. 1, 2023
Background/Aims:
Despite
the
high
efficacy
of
direct-acting
antivirals
(DAAs),
approximately
1–3%
hepatitis
C
virus
(HCV)
patients
fail
to
achieve
a
sustained
virological
response.
We
conducted
nationwide
study
investigate
risk
factors
associated
with
DAA
treatment
failure.
Machine-learning
algorithms
have
been
applied
discriminate
subjects
who
may
respond
therapy.Methods:
analyzed
Taiwan
HCV
Registry
Program
database
explore
predictors
failure
in
patients.
Fifty-five
host
and
features
were
assessed
using
multivariate
logistic
regression,
decision
tree,
random
forest,
eXtreme
Gradient
Boosting
(XGBoost),
artificial
neural
network.
The
primary
outcome
was
undetectable
RNA
at
12
weeks
after
end
treatment.
Results:
training
(n=23,955)
validation
(n=10,346)
datasets
had
similar
baseline
demographics,
an
overall
rate
1.6%
(n=538).
Multivariate
regression
analysis
revealed
that
liver
cirrhosis,
hepatocellular
carcinoma,
poor
adherence,
higher
hemoglobin
A1c
significantly
XGBoost
outperformed
other
models,
area
under
receiver
operating
characteristic
curve
1.000
dataset
0.803
dataset.
top
five
RNA,
body
mass
index,
α-fetoprotein,
platelets,
FIB-4
index.
accuracy,
sensitivity,
specificity,
positive
predictive
value,
negative
value
model
(cutoff
value=0.5)
99.5%,
69.7%,
99.9%,
97.4%,
respectively,
for
entire
dataset.Conclusions:
Machine
learning
effectively
provide
stratification
additional
information
on
Diagnostics,
Год журнала:
2023,
Номер
13(10), С. 1799 - 1799
Опубликована: Май 19, 2023
Background:
Artificial
Intelligence
(AI)-based
Deep
Neural
Networks
(DNNs)
can
handle
a
wide
range
of
applications
in
image
analysis,
ranging
from
automated
segmentation
to
diagnostic
and
prediction.
As
such,
they
have
revolutionized
healthcare,
including
the
liver
pathology
field.
Objective:
The
present
study
aims
provide
systematic
review
performances
provided
by
DNN
algorithms
throughout
Pubmed
Embase
databases
up
December
2022,
for
tumoral,
metabolic
inflammatory
fields.
Results:
42
articles
were
selected
fully
reviewed.
Each
article
was
evaluated
through
Quality
Assessment
Diagnostic
Accuracy
Studies
(QUADAS-2)
tool,
highlighting
their
risks
bias.
Conclusions:
DNN-based
models
are
well
represented
field
pathology,
diverse.
Most
studies,
however,
presented
at
least
one
domain
with
high
risk
bias
according
QUADAS-2
tool.
Hence,
future
opportunities
persistent
limitations.
To
our
knowledge,
this
is
first
solely
focused
on
evaluate
lens
QUADAS2
Liver International,
Год журнала:
2021,
Номер
42(9), С. 2067 - 2079
Опубликована: Сен. 13, 2021
Abstract
Hepatocellular
carcinoma
(HCC)
is
prevalent
worldwide
with
suboptimal
therapeutic
outcomes.
The
advancement
of
options
and
the
development
new
systemic
therapies
expand
armamentarium
to
tackle
HCC.
Treatment
should
be
provided
based
on
hierarchy
efficacy
in
a
multidisciplinary
perspective,
instead
traditional
stage‐guided
scheme.
In
advanced
HCC,
lenvatinib
has
comparable
as
sorafenib
for
first‐line
therapy
HCC;
while
regorafenib,
cabozantinib,
ramucirumab
have
been
approved
second‐line
after
failure
sorafenib.
Immune
checkpoint
inhibitor
prolongs
response
rate
survival
enables
long‐term
cure.
Atezolizumab
plus
bevacizumab
superior
Several
emerging
regimens
by
combination
various
are
currently
under
clinical
trials.
Systemic
may
used
neoadjuvant,
adjuvant
or
even
initial
intermediate‐stage
paradigm
shift
HCC
treatment
will
improve
patient
Cancers,
Год журнала:
2021,
Номер
13(15), С. 3740 - 3740
Опубликована: Июль 26, 2021
Hepatocellular
carcinoma
(HCC)
is
the
most
common
type
of
primary
liver
cancer,
followed
by
cholangiocarcinoma
(CCA).
HCC
third
cause
cancer
death
worldwide,
and
its
incidence
rising,
associated
with
an
increased
prevalence
obesity
nonalcoholic
fatty
disease
(NAFLD).
However,
current
treatment
options
are
limited.
Genetic
factors
epigenetic
factors,
influenced
age
environment,
significantly
impact
initiation
progression
NAFLD-related
HCC.
In
addition,
both
transcriptional
post-transcriptional
modification
critically
important
for
development
in
under
inflammatory
fibrotic
conditions.
The
early
diagnosis
predicts
curative
longer
survival.
clinical
cases
commonly
found
a
very
late
stage
due
to
asymptomatic
nature
diagnostic
methods
novel
biomarkers,
as
well
combined
evaluation
algorithm
artificial
intelligence,
support
precise
HCC,
timely
monitoring
during
progression.
Treatment
include
immunotherapy,
CAR
T
cell
therapy,
peptide
treatment,
bariatric
surgery,
anti-fibrotic
so
on.
Overall,
increasing,
better
understanding
underlying
mechanism
implicated
essential
improving
prognosis.